Literature DB >> 26774853

Allosteric Communication across STAT3 Domains Associated with STAT3 Function and Disease-Causing Mutation.

Andrew T Namanja1, Jianghai Wang1, Ralf Buettner1, Loren Colson1, Yuan Chen2.   

Abstract

STAT3 is a member of STAT (signal transducer and activator of transcription) transcription activators. Aberration in STAT3 activity due to constitutive activation or mutations leads to diseases such as cancer and hyper-immunoglobulin E syndrome (HIES). STAT3 contains several structured domains including the Src homology 2 domain (SH2), linker domain (LD), DNA-binding domain (DBD) and the coiled-coil domain. Here we report the discovery of inter-domain allosteric communications in STAT3 from studies using nuclear magnetic resonance (NMR) and other methods. We found that pTyr-peptide interactions with SH2 cause structural and dynamics changes in LD and DBD. The inter-domain allosteric effect is likely mediated by the flexibility in the hydrophobic core. In addition, a mutation in LD found in HIES (I568F) induces NMR chemical shift perturbation in SH2, DBD and the coiled-coil domain, suggesting conformational changes in these domains. Consistent with conformational changes in SH2, the I568F mutant reduces SH2's binding affinity to a pTyr-containing peptide. This study provides an example of dynamics-dependent allosteric effects, and due to the structural conservation of the STAT family of proteins, the inter-domain allosteric communication observed in STAT3 likely occurs in other STATs.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  HIES; NMR; SH2; STAT3; allostery

Mesh:

Substances:

Year:  2016        PMID: 26774853      PMCID: PMC4767637          DOI: 10.1016/j.jmb.2016.01.003

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  36 in total

Review 1.  Protein identification and analysis tools in the ExPASy server.

Authors:  M R Wilkins; E Gasteiger; A Bairoch; J C Sanchez; K L Williams; R D Appel; D F Hochstrasser
Journal:  Methods Mol Biol       Date:  1999

2.  Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome.

Authors:  Yoshiyuki Minegishi; Masako Saito; Shigeru Tsuchiya; Ikuya Tsuge; Hidetoshi Takada; Toshiro Hara; Nobuaki Kawamura; Tadashi Ariga; Srdjan Pasic; Oliver Stojkovic; Ayse Metin; Hajime Karasuyama
Journal:  Nature       Date:  2007-08-05       Impact factor: 49.962

3.  Quantitative dynamics and binding studies of the 20S proteasome by NMR.

Authors:  Remco Sprangers; Lewis E Kay
Journal:  Nature       Date:  2007-01-21       Impact factor: 49.962

4.  Structural basis for signal-sequence recognition by the translocase motor SecA as determined by NMR.

Authors:  Ioannis Gelis; Alexandre M J J Bonvin; Dimitra Keramisanou; Marina Koukaki; Giorgos Gouridis; Spyridoula Karamanou; Anastassios Economou; Charalampos G Kalodimos
Journal:  Cell       Date:  2007-11-16       Impact factor: 41.582

5.  STAT3 mutations in the hyper-IgE syndrome.

Authors:  Steven M Holland; Frank R DeLeo; Houda Z Elloumi; Amy P Hsu; Gulbu Uzel; Nina Brodsky; Alexandra F Freeman; Andrew Demidowich; Joie Davis; Maria L Turner; Victoria L Anderson; Dirk N Darnell; Pamela A Welch; Douglas B Kuhns; David M Frucht; Harry L Malech; John I Gallin; Scott D Kobayashi; Adeline R Whitney; Jovanka M Voyich; James M Musser; Cristina Woellner; Alejandro A Schäffer; Jennifer M Puck; Bodo Grimbacher
Journal:  N Engl J Med       Date:  2007-09-19       Impact factor: 91.245

6.  Crystal structure of unphosphorylated STAT3 core fragment.

Authors:  Zhiyong Ren; Xiang Mao; Claudia Mertens; Ravi Krishnaraj; Jie Qin; Pijus K Mandal; Michael J Romanowski; John S McMurray; Xiaomin Chen
Journal:  Biochem Biophys Res Commun       Date:  2008-04-21       Impact factor: 3.575

7.  A robust and cost-effective method for the production of Val, Leu, Ile (delta 1) methyl-protonated 15N-, 13C-, 2H-labeled proteins.

Authors:  N K Goto; K H Gardner; G A Mueller; R C Willis; L E Kay
Journal:  J Biomol NMR       Date:  1999-04       Impact factor: 2.835

8.  An efficient protocol for the complete incorporation of methyl-protonated alanine in perdeuterated protein.

Authors:  Isabel Ayala; Remy Sounier; Nathalie Usé; Pierre Gans; Jérôme Boisbouvier
Journal:  J Biomol NMR       Date:  2008-12-30       Impact factor: 2.835

9.  Dynamically driven protein allostery.

Authors:  Nataliya Popovych; Shangjin Sun; Richard H Ebright; Charalampos G Kalodimos
Journal:  Nat Struct Mol Biol       Date:  2006-08-13       Impact factor: 15.369

10.  A single-quantum methyl 13C-relaxation dispersion experiment with improved sensitivity.

Authors:  Patrik Lundström; Pramodh Vallurupalli; Tomasz L Religa; Frederick W Dahlquist; Lewis E Kay
Journal:  J Biomol NMR       Date:  2007-04-27       Impact factor: 2.582

View more
  6 in total

1.  Cytosolic delivery of peptidic STAT3 SH2 domain inhibitors.

Authors:  Robert A Cerulli; Livia Shehaj; Isidora Tosic; Kevin Jiang; Jing Wang; David A Frank; Joshua A Kritzer
Journal:  Bioorg Med Chem       Date:  2020-05-04       Impact factor: 3.641

Review 2.  Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution.

Authors:  Uddalak Bharadwaj; Moses M Kasembeli; Prema Robinson; David J Tweardy
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

3.  Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia.

Authors:  Xi Jiang; Chao Hu; Kyle Ferchen; Ji Nie; Xiaolong Cui; Chih-Hong Chen; Liting Cheng; Zhixiang Zuo; William Seibel; Chunjiang He; Yixuan Tang; Jennifer R Skibbe; Mark Wunderlich; William C Reinhold; Lei Dong; Chao Shen; Stephen Arnovitz; Bryan Ulrich; Jiuwei Lu; Hengyou Weng; Rui Su; Huilin Huang; Yungui Wang; Chenying Li; Xi Qin; James C Mulloy; Yi Zheng; Jiajie Diao; Jie Jin; Chong Li; Paul P Liu; Chuan He; Yuan Chen; Jianjun Chen
Journal:  Nat Commun       Date:  2017-12-13       Impact factor: 14.919

4.  Lycorine Displays Potent Antitumor Efficacy in Colon Carcinoma by Targeting STAT3.

Authors:  Song Wu; Yuling Qiu; Yingying Shao; Shuangshuang Yin; Rui Wang; Xu Pang; Junhong Ma; Chunze Zhang; Bo Wu; Sangho Koo; Lifeng Han; Yi Zhang; Xiumei Gao; Tao Wang; Haiyang Yu
Journal:  Front Pharmacol       Date:  2018-08-08       Impact factor: 5.810

5.  The Selectivity of Fosfosal for STAT5b over STAT5a is Mediated by Arg566 in the Linker Domain.

Authors:  Julian Gräb; Thorsten Berg
Journal:  Chembiochem       Date:  2020-05-08       Impact factor: 3.164

6.  Stafia-1: a STAT5a-Selective Inhibitor Developed via Docking-Based Screening of in Silico O-Phosphorylated Fragments.

Authors:  Kalaiselvi Natarajan; Daniel Müller-Klieser; Stefan Rubner; Thorsten Berg
Journal:  Chemistry       Date:  2019-11-27       Impact factor: 5.236

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.